KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2025)

Historic Other Accumulated Expenses for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $665.0 million.

  • Elanco Animal Health's Other Accumulated Expenses fell 291.97% to $665.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $665.0 million, marking a year-over-year decrease of 291.97%. This contributed to the annual value of $643.0 million for FY2024, which is 5721.27% up from last year.
  • Per Elanco Animal Health's latest filing, its Other Accumulated Expenses stood at $665.0 million for Q3 2025, which was down 291.97% from $596.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Other Accumulated Expenses high stood at $685.0 million for Q3 2024, and its period low was $377.0 million during Q1 2023.
  • For the 5-year period, Elanco Animal Health's Other Accumulated Expenses averaged around $520.6 million, with its median value being $510.0 million (2024).
  • Data for Elanco Animal Health's Other Accumulated Expenses shows a peak YoY increase of 16332.72% (in 2021) and a maximum YoY decrease of 2667.79% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Elanco Animal Health's Other Accumulated Expenses stood at $433.0 million in 2021, then grew by 4.85% to $454.0 million in 2022, then fell by 9.91% to $409.0 million in 2023, then soared by 57.21% to $643.0 million in 2024, then grew by 3.42% to $665.0 million in 2025.
  • Its last three reported values are $665.0 million in Q3 2025, $596.0 million for Q2 2025, and $576.0 million during Q1 2025.